ACTRN12611000479909
Recruiting
未知
Multi-Parametric Cardiovascular Magnetic Resonance Assessment of Hypertrophic Cardiomyopathy
Professor Joseph Selvanayagam0 sites120 target enrollmentMay 9, 2011
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hypertrophic Cardiomyopathy
- Sponsor
- Professor Joseph Selvanayagam
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Hypertrophic cardiomyopathy patients aged between 18 and 75; phenotype positive (established by echocardiography or cardiac magnetic resonance scan); genotype positive for cardiac myosin binding protein\-C gene mutations or cardiac beta\-myosin heavy chain gene mutations.
Exclusion Criteria
- •Impaired LV systolic function (EF \<50%) as detected on echocardiography or cardiac magnetic resonance scan; history of diabetes mellitus, calculated GFR \<30mls/hr; significant derranged liver function defined as liver enzymes of 3 x ULN; current therapy with metformin or amiodarone; absolute contraindication of having MRI scan.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Multi-Parametric Cardiovascular Magnetic Resonance Assessment of Hypertrophic Cardiomyopathy - Therapeutic Metformin sub-studyACTRN12611000495921Professor Joseph Selvanayagam120
Completed
Not Applicable
Cardiovascular Magnetic resonance imaging and Echocardiography in Rheumatoid Arthritis - Patterns of cardiovascular dysfunction in patients with rheumatoid arthritisRArheumatics1008220610023213NL-OMON39670Medisch Spectrum Twente80
Recruiting
Not Applicable
Multi-parametric MRI for Therapeutic Response Prediction in Rectal CancerRectal CancerCancer - Bowel - Back passage (rectum) or large bowel (colon)ACTRN12616001690448Dr Trang Pham35
Recruiting
Not Applicable
Cardiac Magnetic Resonance and Computed Tomography First in Suspected Non-ST-Elevation Myocardial Infarction. An Observational Two-Center StudyNL-OMON54580Medisch Universitair Ziekenhuis Maastricht127
Completed
Phase 2
A study looking at the use of multiparametric Magnetic Resonance Imaging (MRI) and Positron Emission Tomography - Computed Tomography (PET-CT) to evaluate radiological changes after lung stereotactic ablative radiotherapy (SABR).on small cell lung cancer (NSCLC)Oligometastatic disease involving lungNon small cell lung cancer (NSCLC)Cancer - Lung - Non small cellCancer - Other cancer typesACTRN12616000801415iverpool Hospital23